Skip to main content
  • Saved

made a Post

Prognostic impact of KRAS G12C mutation in patients with NSCLC: results from the ETOP Lungscape Project - PubMed

Prognostic impact of KRAS G12C mutation in patients with NSCLC: results from the ETOP Lungscape Project - PubMed

Source :

https://pubmed.ncbi.nlm.nih.gov/33647504/

1 St. James Hospital, Institute of Molecular Medicine, Dublin, Ireland. Electronic address: stephen.finn@tcd.ie. 2 University Hospital Geneva, Department of Oncology, Geneva, Switzerland. 3 Frontier Science Foundation-Hellas, ETOP Statistics Center and School of Health Sciences, Department of Nursing, National and Kapodistrian University of Athens, Athens, Greece. 4 Free University Medical Center, Department of Pathology, Amsterdam, Netherlands.